Articles

P1.02 In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

BJH - volume 6, issue Abstract Book BHS, january 2015

dr. K. Maes , E. De Smedt , A. Kassambara , D. Hose , A. Seckinger , E. Van Valckenborgh PhD, E. Menu , B. Klein , K. Vanderkerken PhD, J. Moreaux , E. De Bruyne

Read more

O.5 In vivo gene expression profiling in the murine 5T33MM model identifies epigenetic-regulated genes predictive for prognosis and drug-sensitivity

BJH - volume 5, issue Abstract Book BHS, january 2014

dr. K. Maes , E. De Smedt , D. Hose , E. Van Valckenborgh PhD, E. Menu , B. Klein , K. Vanderkerken PhD, J. Moreaux , E. De Bruyne

Read more
X